Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes

Hormone and Metabolic Research

Volumn 37, Issue 7, 2005, Pages 450-454

  Kinalski, M ^a   Telejko, B ^a   Kuzmicki M ^a   Kretowski A ^a   Kinalska, I ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adiponectin; Gestational diabetes mellitus; sTNFR 1; sTNFR 2; Tumor necrosis factor

Indexed keywords

ADIPONECTIN; C PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; OBESITY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; ANTHROPOMETRY; BODY MASS INDEX; DIABETES, GESTATIONAL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23144439637     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870238     Document Type: Article

References (39)

1. Zuopas C. Gestational diabetes mellitus. Diabetes Rev Int 1995; 4: 5-7
2. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EAH. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 1991; 165: 1667-1672
3. Buchanan TA, Metzger BE, Freinkel N, Berman RN. Insulin sensitivity and beta-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990; 162: 1008-1014
4. Gilbert M, Basile S, Buadelin A, Pere MC. Lowering plasma free fatty acid levels improves insulin action in conscious pregnant rabbits. Am J Physiol 1993; 264: E576-E582
5. Stehbens WE. The epidemiological relationship of hypercholesterolemia, hypertension, diabetes mellitus and obesity to coronary heart disease and atherogenesis. J Clin Epidemiol 1990; 43: 733-741
6. Pi-Sunyer FX. Comorbidities of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999; 31: S602-S608
7. Hotamisligil GS, Spigelman BM. Tumor necrosis factor alpha - a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278
8. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor-α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854-4858
9. Stephens JN, Lee J, Pilch PF. Tumor necrosis factor-α induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997; 272: 971-976
10. Daher S, Fonseca F, Ribeioro OG, Musatti CC, Gerbase-DeLima M. Tumor necrosis factor during pregnancy and at the onset of labour and spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 1999; 83: 77-79
11. Argiles JM, Carbo N, Lopes-Soriano FJ. TNF and pregnancy: the paradigm of a complex interaction. Cytokine Growth Factor Rev 1997; 8: 181-188
12. Kirwan JP, Hauguel-de Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JF, Kalhan SC, Catalano PM. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-2213
13. Coughlan MT, Oliva K, Georgiou HM, Parmezel JMH, Rice GE. Glucose-induced release of tumor necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 2001; 18: 921-927
14. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1987; 46: 451-455
15. Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998; 47: 1757-1762
16. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q produced extensively in adipocytes. J Biol Chem 1995; 270: 26746-26749
17. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703
18. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardas C, Tataranni PA. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002; 50: 1884-1888
19. Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 2002; 80: 696-702
20. Arita Y, Kihara S, Oguchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Schimomura I, Nakamura T, Miyoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys Res Commun 1996; 257: 79-83
21. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935
22. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Schimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y. Association of hypoadiponectinemia and coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89
23. Iwahashi H, Funahashi T, Kurokawa, Sayama K, Fukuda E, Okita K, Imagawa A, Yamagata K, Shimomura I, Miyagawa J-I, Matsuzawa Y. Plasma adiponectin levels in women with anorexia nervosa. Horm Metab Res 2003; 35: 537-540
24. Brichard SM, Delporte MI, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res 2003; 35: 337-342
25. Maeda N, Shimomura I, Kishida K. Diet-induced insulin resistance in mice lacking adiponectin/Acrp30. Nat Med 2002; 8: 731-737
26. Hotamisligl GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415
27. Friedewald WT, Levy RI, Fredrickson PS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-506
28. Winkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajos P, Salamon F, Turi Z, Kovacs M, Vargha P, Karadi I. Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract 2002; 56: 93-99
29. Melczer ZS, Banhidy F, Csomor S Jr, Kovasc M, Siklos P, Winkler G, Cseh K. Role of tumor necrosis factor-α in insulin resistance during normal pregnancy. Eur J Obstet Gynecol and Reprod Biol 2002; 105: 7-10
30. Cseh K, Baranyi E, Melczer Z, Csakany GM, Speer G, Kovacs M, Gero G, Karadi I, Winkler G. The pathophysiological influence of leptin and the tumor necrosis factor system on maternal insulin resistance: negative correlation with anthropometric parameters of neonates in gestational diabetes. Gynecol Endocrinol 2002; 16: 453-460
31. Hotamisligil GS. Mechanisms of TNF-α induced insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 119-125
32. Cseh K, Winkler G, Melczer Z. The role of tumor necrosis factor (TNF)-α resistance in obesity and insulin resistance. Diabetologia 2000; 43: 525
33. Hulthe J, Hulten LM, Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 2003; 52: 1612-1614
34. Cseh K, Baranyi E, Melczer Z, Kaszas E, Palik E, Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 2004; 27: 274-275
35. Retnakaran R, Hanley AJG, Raif N, Connely PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes. Diabetes Care 2004; 27: 799-800
36. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004; 83: 341-347
37. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 2306-2311
38. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indians population. Lancet 2002; 360: 57-58
39. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 2003; 26: 2015-2020